Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Vopr Virusol ; 35(4): 338-42, 1990.
Artigo em Russo | MEDLINE | ID: mdl-2256320

RESUMO

Chemical drugs and the Soviet interferon inducer larifan as well as their combinations were evaluated in genital herpes in male guinea pigs. Among the chemical drugs tested, the highest efficacy was observed with 2% phosphonoformic acid trisodiate ointment (its therapeutic effect 62%). The efficacy of 2% cycloguanosine ointment and 0.5% phosphonoacetic ointment did not exceed 43% and 36%, respectively. Topical and systemic use of the interferon inducer larifan produced a marked therapeutic effect (63%). Combined use of purophosphate and cycloguanosine analogues was more effective than the agents alone, yet the effect of the combinations being nothing more than additive.


Assuntos
Antivirais/uso terapêutico , Modelos Animais de Doenças , Herpes Genital/tratamento farmacológico , Indutores de Interferon/uso terapêutico , RNA de Cadeia Dupla/uso terapêutico , Animais , Avaliação Pré-Clínica de Medicamentos , Quimioterapia Combinada , Cobaias , Masculino , Fatores de Tempo
2.
Vopr Virusol ; 34(4): 466-74, 1989.
Artigo em Russo | MEDLINE | ID: mdl-2555965

RESUMO

Nationally synthesized chemopreparations: phosphonoacetic (PAA), phosphonoformic (PFA) acids and acycloguanosine (Acg) exhibit a marked antiherpetic effect in cell cultures and marked protective effect in herpes meningoencephalitis in mice induced by intraperitoneal inoculation of herpes simplex virus type 1 (HSV-1) (43% PFA, 33% PAA, 25% Acg). Both in vitro and in vivo (mouse meningoencephalitis), PFA (its trisodium salt) on the whole proved to be less toxic than PAA but exerted a higher or similar antiherpetic effect. The combined use of pyrophosphate analogues (PAA, PFA) with Acg is more effective that their use separately both in vitro and in herpes meningoencephalitis in mice an produces an additive effect or one similar to it. Systemic inoculation of interferon inducers, lafarine or ridostine, is effective in herpes meningoencephalitis in mice induced by intraperitoneal inoculation of HSV-1 (the protective effect 33% and 26%, respectively). The combined use of ridostine and PAA in herpes meningoencephalitis in mice led to synergistic effect.


Assuntos
Herpes Simples/terapia , Indutores de Interferon/uso terapêutico , Meningoencefalite/terapia , Ácido Fosfonoacéticos/análogos & derivados , Ácido Fosfonoacéticos/uso terapêutico , Aciclovir/uso terapêutico , Animais , Células Cultivadas , Embrião de Galinha , Chlorocebus aethiops , Terapia Combinada , DNA/biossíntese , DNA/efeitos dos fármacos , Foscarnet , Herpes Simples/microbiologia , Meningoencefalite/microbiologia , Camundongos , Ácido Fosfonoacéticos/toxicidade , Simplexvirus/isolamento & purificação , Células Vero
3.
Vopr Virusol ; 34(2): 186-92, 1989.
Artigo em Russo | MEDLINE | ID: mdl-2527446

RESUMO

A comparative analysis of the effectiveness of national phosphonic acid derivatives (FUK and FMK) and acyclic nucleoside, acycloguanosine (Acg), as well as interferon (INF) inducers, lafarin and ridostin, was carried out on the model of herpetic conjunctivitis in rabbits and guinea pigs. Upon therapeutic-prophylactic administration, lafarin reduced the intensity of eye symptoms 2-fold as compared with the controls (infected but untreated guinea-pigs). In rabbits with herpetic conjunctivitis, the therapeutic schedule of the use of FMK (FUK) and Acg shortened the duration of the disease by 7 and 11 days, respectively, as compared with the control. The combined use of chemical drugs and INF inducers, lafarin or ridostin, reduced the intensity of the disease manifestations 3-fold and shortened the duration of the disease by 8-11 days. The survival rate was 80%-100%. Use of the combination of the two chemical drugs gave an additive effect. The synergistic effect was observed with FMK used in combination with lafarin.


Assuntos
Indutores de Interferon/uso terapêutico , Ceratite Dendrítica/tratamento farmacológico , Compostos Organofosforados/uso terapêutico , Ácido Fosfonoacéticos/uso terapêutico , Animais , Cefalexina/uso terapêutico , Modelos Animais de Doenças , Avaliação Pré-Clínica de Medicamentos , Quimioterapia Combinada , Feminino , Foscarnet , Cobaias , Masculino , Ácido Fosfonoacéticos/análogos & derivados , RNA de Cadeia Dupla/uso terapêutico , RNA Fúngico/uso terapêutico , Coelhos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...